Cost-effectiveness of nab-paclitaxel plus gemcitabine versus erlotinib plus gemcitabine in metastatic pancreatic cancer.
E. Gabriela Chiorean
Research Funding - Celgene
Scott Whiting
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Gary Binder
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
George Dranitsaris
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Victoria Manax
Employment or Leadership Position - Celgene
Stock Ownership - Celgene